Abstract
Vonoprazan (VPZ) is a novel promising member of gastric acid-suppressive medicinal administrated in Japan in 2015. Only a few HPLC analysis protocols were reported for VPZ assaying, therefore, the present work describes for the first time a novel copper oxide nanoparticles-based sensor as a promising analytical tool for differential pulse voltammetric determination of vonoprazan with enhanced sensitivity compared with the bare electrode. An irreversible oxidation process with the two-electron transfer was elucidated with scan rate measurements. At the optimized conditions, peak heights showed against VPZ in the concentration range from 0.99 to 20.00 µg mL−1, and detection limit of 0.24 µg mL−1. The proposed sensor showed prolonged stability with a 95% recovery of the original peak height within the first 30 days. Good reproducibility and repeatability of the fabrication protocol was reported with RSD 1.3%. Noticeable resolution between the VPZ, ascorbic acid, and uric voltammetric peaks allows accurate assaying of VPZ in biological fluids with average recoveries agreeable with the conventional HPLC techniques.